Status:
COMPLETED
Dexmedetomidine in TAP Block for Inguinal Hernia Repair
Lead Sponsor:
Aretaieion University Hospital
Conditions:
Inguinal Hernia
Analgesia
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This prospective double-blind randomized study will aim at evaluating the short- and long-term postoperative analgesic efficacy of the ultrasound-guided transversus abdominis plane (TAP) block with a ...
Detailed Description
Inguinal hernia repair is one of the most commonly performed surgical procedures worldwide, especially in the day-case setting. It can be accompanied by moderate to severe postoperative pain, which ca...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists (ASA) patients I-III undergoing inguinal hernia repair with a mesh
- open hernia repair
- elective surgery
Exclusion
- inability to consent to the study due to language barriers or cognitive dysfunction -
- bilateral inguinal hernia repair,
- body mass index over 40 kg m-2,
- skin infection at the puncture site
- contraindication to paracetamol or non-steroidal anti-inflammatory drug (NSAIDs) administration
- known previous hepatic or renal impairment as assessed by the patients' history and routine biochemical markers
- coagulation abnormalities
- history of gastroesophageal reflux and preoperative use of opioids or NSAIDs for chronic pain conditions
- reoperation of recurrent inguinal hernia after previous mesh repair
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04403711
Start Date
April 1 2018
End Date
December 31 2023
Last Update
July 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aretaieion University Hospital
Athens, Attica, Greece, 11528